These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21270457)

  • 1. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
    Thomas AJ; DaSilva JN; Lortie M; Renaud JM; Kenk M; Beanlands RS; deKemp RA
    J Nucl Med; 2011 Feb; 52(2):263-9. PubMed ID: 21270457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
    Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
    Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
    Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET.
    Fujita M; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Lu JQ; Liow JS; Seneca N; Tipre DN; Cropley VL; Imaizumi M; Gee AD; Seidel J; Green MV; Pike VW; Innis RB
    Neuroimage; 2005 Jul; 26(4):1201-10. PubMed ID: 15961054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.
    Lourenco CM; Kenk M; Beanlands RS; DaSilva JN
    Life Sci; 2006 Jun; 79(4):356-64. PubMed ID: 16499932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
    Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
    Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of r-[11C]rolipram for PET imaging of phosphodieterase-4: in vivo binding, metabolism, and dosimetry studies in rats.
    Lourenco CM; Houle S; Wilson AA; DaSilva JN
    Nucl Med Biol; 2001 May; 28(4):347-58. PubMed ID: 11395307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: a retest study and use of an image-derived input function.
    Zanotti-Fregonara P; Zoghbi SS; Liow JS; Luong E; Boellaard R; Gladding RL; Pike VW; Innis RB; Fujita M
    Neuroimage; 2011 Feb; 54(3):1903-9. PubMed ID: 21034834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.
    Fujita M; Imaizumi M; D'Sa C; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Gee AD; Seidel J; Green MV; Pike VW; Duman RS; Innis RB
    Synapse; 2007 Feb; 61(2):78-86. PubMed ID: 17117418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
    Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
    Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography.
    DaSilva JN; Lourenco CM; Meyer JH; Hussey D; Potter WZ; Houle S
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1680-3. PubMed ID: 12458404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats.
    Greene M; Thackeray JT; Kenk M; Thorn SL; Bevilacqua L; Harper ME; Beanlands RS; Dasilva JN
    Can J Physiol Pharmacol; 2009 Mar; 87(3):196-202. PubMed ID: 19295660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of human brain PDE4 occupancy by GSK356278: A [
    van der Aart J; Salinas C; Dimber R; Pampols-Maso S; Weekes AA; Tonkyn J; Gray FA; Passchier J; Gunn RN; Rabiner EA
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2033-2040. PubMed ID: 28737056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder.
    Fujita M; Hines CS; Zoghbi SS; Mallinger AG; Dickstein LP; Liow JS; Zhang Y; Pike VW; Drevets WC; Innis RB; Zarate CA
    Biol Psychiatry; 2012 Oct; 72(7):548-54. PubMed ID: 22677471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
    Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
    Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
    Vargas ML; Hernandez J; Kaumann AJ
    Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET.
    Lortie M; DaSilva JN; Kenk M; Thorn S; Davis D; Birnie D; Beanlands RS; deKemp RA
    Mol Imaging Biol; 2012 Apr; 14(2):225-36. PubMed ID: 21424298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats.
    Itoh T; Abe K; Hong J; Inoue O; Pike VW; Innis RB; Fujita M
    Synapse; 2010 Feb; 64(2):172-6. PubMed ID: 19852069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.